Your session is about to expire
← Back to Search
Device
Ear Tube Insertion Device for Ear Infections (VENTY Trial)
N/A
Recruiting
Research Sponsored by AventaMed DAC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a device that helps doctors put small tubes in children's eardrums. It targets kids who need this procedure to prevent ear infections. The device works by making it easier to place the tubes, which help drain fluid from the ear.
Who is the study for?
This trial is for children aged 6 months to under 13 years who need ear tubes inserted due to infections. They must be able to attend follow-up visits.
What is being tested?
The study is testing the Solo+ Tympanostomy Tube Device (Solo+ TTD) for safety and effectiveness in placing ear tubes during a standard procedure in pediatric patients.
What are the potential side effects?
Potential side effects are not specified, but may include typical risks associated with tympanostomy procedures such as pain, infection, or hearing issues.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Procedure Success
Rate of Adverse Events
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Solo+ Tympanostomy Tube Device (Solo+ TTD)Experimental Treatment1 Intervention
The Solo+ TTD is a disposable surgical tool designed to deliver a tympanostomy tube into the tympanic membrane of patients undergoing a tympanostomy tube placement procedure.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Tympanostomy tubes, also known as ear tubes, are commonly used to treat chronic ear infections by ventilating the middle ear and preventing fluid accumulation. The mechanism involves creating a small opening in the eardrum to insert the tube, which allows air to enter the middle ear and fluid to drain out, reducing the risk of infection and improving hearing.
This is particularly important for patients with recurrent or chronic otitis media, as it helps to alleviate symptoms, prevent complications, and reduce the need for repeated antibiotic treatments.
Clinical approach to treatment of otitis media.
Clinical approach to treatment of otitis media.
Find a Location
Who is running the clinical trial?
AventaMed DACLead Sponsor
3 Previous Clinical Trials
74 Total Patients Enrolled
Matija DanielStudy ChairQueen's Medical Center
3 Previous Clinical Trials
74 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have narrow ear canals.My ear structure prevents safe use of the Solo+ TTD device.I have a birth defect affecting my ear.I cannot have my eardrum fully checked due to my anatomy.My family has a history of not responding to anesthesia.I am scheduled for ear tube surgery.I am between 6 months and 12 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Solo+ Tympanostomy Tube Device (Solo+ TTD)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.